Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aminoacyl-tRNA accommodation at the A site of the ribosome is a critical step in protein synthesis during translation. It refers to the process by which an aminoacyl-tRNA (aa-tRNA)—a tRNA molecule charged with its corresponding amino acid—moves from a partially bound, pre-accommodation state (A/T state) into a fully accommodated position (A/A state) within the ribosomal A site. This movement positions the 3′-CCA end of aa-tRNA into the peptidyl transferase center (PTC), enabling peptide bond formation with the growing polypeptide chain. The process is multistep and involves significant conformational changes in both tRNA and ribosomal RNA. Proper accommodation ensures fidelity during translation: only correctly paired aa-tRNAs are efficiently accommodated for peptide bond formation.
Not applicable as this is a biological process, not a drug target directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aminoacyl-tRNA Accommodation at the A Site of the Ribosome (None).